Status:
COMPLETED
Clinical Outcome of Electrical Transcutaneous Auricular Vagal Stimulation in Patients With Stable Symptomatic Chronic Heart Failure
Lead Sponsor:
Medical University of Vienna
Conditions:
Chronic Heart Failure
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
This study aims to investigate whether electrical vagus nerve stimulation in the auricle has an impact on the clinical presentation of heart failure. The device used, P-STIM, is already successfully a...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Chronic heart failure
- NYHA Classification II-III
- Stable medication since at least 1 months
- LVEF \<40%
- Patients must be able to understand study conditions
- No exclusion criteria
- Signed informed consent 6.1.3 Exclusion criteria
- Any electrical auricular vagal stimulation treatment within 6 months prior to base line visit
- Participation in another clinical trial within 3 months prior to base line visit
- Ventricular tachyarrhythmia within 1 month prior to base line visit
- Psoriasis vulgaris
- Hemophilia
- Cardiac pace makers
Exclusion
Key Trial Info
Start Date :
January 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 31 2016
Estimated Enrollment :
13 Patients enrolled
Trial Details
Trial ID
NCT06950320
Start Date
January 1 2014
End Date
January 31 2016
Last Update
April 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University of Vienna
Vienna, Austria, 1090